Geneos Wealth Management’s Pediatrix Medical MD Stock Holding History

Geneos Wealth Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52	Closed	-$746	–	2897
2025 Q2	$746	Buy	52 +8	+18%	+$110	﹤0.01%	3049
2025 Q1	$1.28K	Buy	+44	New	+$625	﹤0.01%	3027
2024 Q2	–	Sell	-66	Closed	-$662	–	2139
2024 Q1	$662	Buy	+66	New	+$614	﹤0.01%	2093
2021 Q2	–	Sell	-2,327	Closed	-$61K	–	3008
2021 Q1	$61K	Sell	2,327 -2,327	-50%	-$59.6K	﹤0.01%	1529
2020 Q4	$122K	Buy	+4,654	New	+$87.4K	﹤0.01%	1046
2019 Q1	–	Sell	-35	Closed	-$1K	–	2447
2018 Q4	$1K	Hold	35	–	–	﹤0.01%	2314
2018 Q3	$1K	Hold	35	–	–	﹤0.01%	2357
2018 Q2	$1K	Hold	35	–	–	﹤0.01%	2202
2018 Q1	$1K	Hold	35	–	–	﹤0.01%	2112
2017 Q4	$1K	Hold	35	–	–	﹤0.01%	2111
2017 Q3	$1K	Hold	35	–	–	﹤0.01%	2058
2017 Q2	$2K	Hold	35	–	–	﹤0.01%	1940
2017 Q1	$2K	Hold	35	–	–	﹤0.01%	1902
2016 Q4	$2K	Sell	35 -36	-51%	-$2.34K	﹤0.01%	1876
2016 Q3	$4K	Hold	71	–	–	﹤0.01%	1637
2016 Q2	$5K	Hold	71	–	–	﹤0.01%	1523
2016 Q1	$4K	Buy	+71	New	+$4.71K	﹤0.01%	1552

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geneos Wealth Management's MD Position: Q3 2025 in Review

Geneos Wealth Management sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 52 shares — an estimated $746 sold.

Geneos Wealth Management first reported a position in MD in Q1 2016 and held it in 17 quarters. The position peaked at $122K in Q4 2020. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

Geneos Wealth Management reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 52 Pediatrix Medical shares in Q3 2025, an estimated $746.
Geneos Wealth Management first reported a position in Pediatrix Medical in Q1 2016 and held it in 17 quarters.
Geneos Wealth Management's Pediatrix Medical position peaked at $122K in Q4 2020.
268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.